Search research articles
Contact Us
Filters
Showing results (151-160 of 379) with videos related to
Page
of 38
Sort By:
Plos One
|
May 3, 2011
Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
Andreas Draube, Nela Klein-González, Stefanie Mattheus, et al.
Expert Review of Anticancer Therapy
|
September 15, 2010
The role of PET in Hodgkin's lymphoma and its impact on radiation oncology
Carsten Kobe, Markus Dietlein, Jan Kriz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2005
Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group
Andreas Engert, Veronika Ballova, Heinz Haverkamp, et al.
Journal of the National Cancer Institute
|
August 31, 2007
Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma
Olaf Weingart, Fareed A Rehan, Holger Schulz, et al.
Annals of Hematology
|
November 15, 2006
Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma
Michal Sieniawski, Oliver Staak, Jan-Peter Glossmann, et al.
Leukemia & Lymphoma
|
May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation
Bastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Hemasphere
|
November 15, 2019
The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered
Peter Borchmann, Alexander Fosså, Monika Długosz-Danecka, et al.
European Journal of Haematology. Supplementum
|
July 13, 2005
CT and MR imaging in Hodgkin's disease--present and future
Axel Gossmann, Hans Theodor Eich, Andreas Engert, et al.
British Journal of Haematology
|
April 27, 2011
BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines
Katrin Ullrich, Kathrin D Wurster, Björn Lamprecht, et al.
The Cochrane Database of Systematic Reviews
|
November 12, 2014
Aerobic physical exercise for adult patients with haematological malignancies
Nils Bergenthal, Andrea Will, Fiona Streckmann, et al.
Page
of 38
Search research articles
Search
Showing results (151-160 of 379) with videos related to
Sort By:
Page
of 38
Plos One
|
May 3, 2011
Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
Andreas Draube, Nela Klein-González, Stefanie Mattheus, et al.
Expert Review of Anticancer Therapy
|
September 15, 2010
The role of PET in Hodgkin's lymphoma and its impact on radiation oncology
Carsten Kobe, Markus Dietlein, Jan Kriz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2005
Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group
Andreas Engert, Veronika Ballova, Heinz Haverkamp, et al.
Journal of the National Cancer Institute
|
August 31, 2007
Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma
Olaf Weingart, Fareed A Rehan, Holger Schulz, et al.
Annals of Hematology
|
November 15, 2006
Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma
Michal Sieniawski, Oliver Staak, Jan-Peter Glossmann, et al.
Leukemia & Lymphoma
|
May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation
Bastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Hemasphere
|
November 15, 2019
The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered
Peter Borchmann, Alexander Fosså, Monika Długosz-Danecka, et al.
European Journal of Haematology. Supplementum
|
July 13, 2005
CT and MR imaging in Hodgkin's disease--present and future
Axel Gossmann, Hans Theodor Eich, Andreas Engert, et al.
British Journal of Haematology
|
April 27, 2011
BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines
Katrin Ullrich, Kathrin D Wurster, Björn Lamprecht, et al.
The Cochrane Database of Systematic Reviews
|
November 12, 2014
Aerobic physical exercise for adult patients with haematological malignancies
Nils Bergenthal, Andrea Will, Fiona Streckmann, et al.
Page
of 38